Bringing the fundamentals into focus…
Back to Clinuvel Pharmaceuticals Limited
How Clinuvel Pharmaceuticals Limited stacks up
CUVL · against 315 other Healthcare companies of similar size
Profitability
92/ 100
Near the top of its peers.
Ranked #11 of 316 · scores higher than 97% of peers
Bars: peers in each 10-point band of the profitability score19 peers with a profitability score of 90–100, including CUVL · Click a bar to see the companies
Why profitability scores 92?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin and return on assets, which are stronger than most Healthcare peers.
- Return on invested capital is not reported, so it is left out of the score.
- a higher return on assets: stronger than 88% of peers. Return on assets: 8.9% vs peer median 1.7%
- a wider operating margin: stronger than 97% of peers. Operating margin: 42.1% vs peer median 7.1%
Metric by metric
Position: dot = CUVL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CUVL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 277 reported | Not reported | -0.8% | — | — | 33% |
| Operating marginHigher is better · 295 reported | 42.1% | 2.0% | 98% | 33% | |
| Return on assetsHigher is better · 317 reported | 8.9% | -0.5% | 94% | 33% | |
| Return on equityHigher is better · 296 reported | 13.2% | -0.8% | 89% | Context only | |
| Gross marginHigher is better · 332 reported | 83.2% | 38.3% | 89% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around CUVL| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 261M USD | 98 | 97 | |
| 3 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 3 | 356M AUD (≈$235M) | 97 | 81 | |
| 5 | 592M ILS (≈$160M) | 96 | 84 | |
| 6 | 157M USD | 95 | ||
| 9 | 353M EUR (≈$388M) | 94 | 77 | |
| 10 | 582M AUD (≈$384M) | 93 | 74 | |
| 11 | 2.3B CNY (≈$318M) | 92 | 68 | |
| 11 | 256M USD | 92 | 80 | |
| 13 | 3.8B HKD (≈$484M) | 91 | 65 | |
| 13 | 449M USD | 91 | 72 | |
| 13 | 4.6B SEK (≈$456M) | 91 | 64 | |
| 13 | 298M CHF (≈$342M) | 91 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score